JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NVO
651
Novo Nordisk
NVO
$165B
| $146M | 0.02% |
1,834,510
-160,970
| -8% | -$11.4M |
2013 Q2
39 quarters
|
|
652
iRhythm Holdings
IRTC
$3.64B
| $145M | 0.02% |
1,173,027
+40,312
| +4% | +$4.37M |
2016 Q4
25 quarters
|
|
653
HealthEquity
HQY
$7.45B
| $145M | 0.02% |
2,474,430
+331,735
| +15% | +$20.1M |
2014 Q3
34 quarters
|
|
654
Archer Daniels Midland
ADM
$38.8B
| $145M | 0.02% |
1,822,499
+236,224
| +15% | +$19.3M |
2013 Q2
39 quarters
|
|
655
PUT
Comcast
CMCSA
$76.5B
| $144M | 0.02% |
3,789,000
-9,229,800
| -71% | -$349M |
2016 Q2
27 quarters
|
|
656
iShares Global Tech ETF
IXN
$9.99B
| $143M | 0.02% |
2,639,050
-119,150
| -4% | -$5.94M |
2015 Q4
29 quarters
|
|
657
Ford
F
$48.2B
| $143M | 0.02% |
11,372,816
+571,923
| +5% | +$7.16M |
2013 Q2
39 quarters
|
|
658
Helen of Troy
HELE
$623M
| $143M | 0.02% |
1,498,564
+328,791
| +28% | +$35.2M |
2013 Q2
39 quarters
|
|
659
RenaissanceRe
RNR
$13.5B
| $142M | 0.02% |
710,859
+3,400
| +0.5% | +$685K |
2013 Q2
39 quarters
|
|
660
Ryman Hospitality Properties
RHP
$8.39B
| $142M | 0.02% |
1,578,645
+4,345
| +0.3% | +$385K |
2015 Q3
30 quarters
|
|
661
KBR
KBR
$4.32B
| $142M | 0.02% |
2,572,110
+116,016
| +5% | +$6.07M |
2017 Q4
21 quarters
|
|
662
Matador Resources
MTDR
$6.62B
| $141M | 0.02% |
2,966,469
-123,602
| -4% | -$6.95M |
2015 Q2
31 quarters
|
|
663
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $141M | 0.02% |
1,541,585
-34,426
| -2% | -$3.12M |
2013 Q2
39 quarters
|
|
664
Avery Dennison
AVY
$12.9B
| $140M | 0.02% |
782,743
-155,347
| -17% | -$28.2M |
2013 Q2
39 quarters
|
|
665
iShares China Large-Cap ETF
FXI
$3.96B
| $140M | 0.02% |
4,728,760
+1,704,281
| +56% | +$51.2M |
2013 Q2
39 quarters
|
|
666
Landstar System
LSTR
$5.89B
| $140M | 0.02% |
778,972
+5,821
| +0.8% | +$1.02M |
2013 Q2
39 quarters
|
|
667
Wintrust Financial
WTFC
$9.78B
| $140M | 0.02% |
1,913,872
+75,040
| +4% | +$6.42M |
2013 Q2
39 quarters
|
|
668
CALL
Regeneron Pharmaceuticals
REGN
$75.7B
| $140M | 0.02% |
169,900
+148,300
| +687% | +$112M |
2022 Q1
4 quarters
|
|
669
iShares Semiconductor ETF
SOXX
$50.2B
| $140M | 0.02% |
941,724
+118,101
| +14% | +$16.1M |
2015 Q2
31 quarters
|
|
670
RBC Bearings
RBC
$16.3B
| $139M | 0.02% |
598,311
+16,665
| +3% | +$3.84M |
2013 Q2
39 quarters
|
|
671
XP
XP
$10.9B
| $139M | 0.02% |
11,721,813
-991,926
| -8% | -$14.1M |
2019 Q4
13 quarters
|
|
|
AUY
672
DELISTED
Yamana Gold, Inc.
AUY
| $139M | 0.02% |
23,704,094
-6,543,610
| -22% | -$37.2M |
2013 Q2
39 quarters
|
|
673
KLA
KLAC
$270B
| $138M | 0.02% |
3,453,590
+1,219,870
| +55% | +$48.1M |
2013 Q2
39 quarters
|
|
674
Vale
VALE
$58.6B
| $138M | 0.02% |
8,728,703
+787,877
| +10% | +$13.3M |
2013 Q2
39 quarters
|
|
675
Freshpet
FRPT
$2.9B
| $137M | 0.02% |
2,075,000
+458,570
| +28% | +$28.2M |
2014 Q4
33 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.